Advances in Recombinant Adeno-Associated Virus Vectors for Neurodegenerative Diseases

Recombinant adeno-associated virus (rAAV) vectors are gene therapy delivery tools that offer a promising platform for the treatment of neurodegenerative diseases. Keeping up with developments in this fast-moving area of research is a challenge. This review was thus written with the intention to intr...

Full description

Bibliographic Details
Published in:	Biomedicines
Main Authors:	Leyao Li, Lakshmy Vasan, Bryan Kartono, Kevan Clifford, Ahmadreza Attarpour, Raghav Sharma, Matthew Mandrozos, Ain Kim, Wenda Zhao, Ari Belotserkovsky, Claire Verkuyl, Gerold Schmitt-Ulms
Format:	Article
Language:	English
Published:	MDPI AG 2023-10-01
Subjects:	adeno-associated virus capsid gene therapy gene editing all-in-one neurodegenerative diseases
Online Access:	https://www.mdpi.com/2227-9059/11/10/2725

Similar Items

Development and implementation of an LC-MS-based multi-attribute method for adeno-associated virus
by: Thomas W. Powers, et al.
Published: (2025-09-01)

Structural and Functional Characterization of Porcine Adeno-Associated Viruses
by: Austin Nelson, et al.
Published: (2025-09-01)

Adeno-Associated Virus Vectors in Retinal Gene Therapy: Challenges, Innovations, and Future Directions
by: Jiayu Huang, et al.
Published: (2025-06-01)

Therapeutic Application and Structural Features of Adeno-Associated Virus Vector
by: Yasunari Matsuzaka, et al.
Published: (2024-08-01)

Efficient Gene Expression in Human Stem Cell Derived-Cortical Organoids Using Adeno Associated Virus
by: Ann-Na Cho, et al.
Published: (2022-10-01)

Gene Therapy for Human Diseases: Recent Achievements and Near-Term Development Prospects
by: K. A. Aitbaev, et al.
Published: (2022-10-01)

Development of recombinant adeno-associated virus empty capsids as a reference standard for quality control of gene therapy products
by: A. V. Tumaev, et al.
Published: (2024-07-01)

Adeno‐associated virus vectors for gene therapy—focusing on melanoma
by: Xingyue Wang, et al.
Published: (2024-10-01)

A novel approach to quantitate biodistribution and transduction of adeno-associated virus gene therapy using radiolabeled AAV vectors in mice
by: Hongzhi Wang, et al.
Published: (2024-09-01)

Gene therapies for osteoarthritis: progress and prospects
by: Anais Defois, et al.
Published: (2024-06-01)

Fantastic AAV Gene Therapy Vectors and How to Find Them—Random Diversification, Rational Design and Machine Learning
by: Jonas Becker, et al.
Published: (2022-07-01)

A comprehensive review of AAV-mediated strategies targeting microglia for therapeutic intervention of neurodegenerative diseases
by: Livia Zhou, et al.
Published: (2024-09-01)

Efficient transduction and optogenetic stimulation of retinal bipolar cells by a synthetic adeno‐associated virus capsid and promoter
by: Therese Cronin, et al.
Published: (2014-08-01)

Biolayer interferometry for adeno-associated virus capsid titer measurement and applications to upstream and downstream process development
by: Thomas M. Leibiger, et al.
Published: (2024-09-01)

Size does matter: overcoming the adeno-associated virus packaging limit
by: Flotte Terence R
Published: (2000-07-01)

Adipose Tissue: An Emerging Target for Adeno-associated Viral Vectors
by: Rhiannon Bates, et al.
Published: (2020-12-01)

Editorial: Application of gene editing in neurodegenerative diseases, volume II
by: Fangfang Qi, et al.
Published: (2023-10-01)

Structural characterization and epitope mapping of the AAVX affinity purification ligand
by: Mario Mietzsch, et al.
Published: (2024-12-01)

Live-cell microarray surface coatings supporting reverse transduction by adeno-associated viruses
by: Kellie I. McConnell, et al.
Published: (2011-10-01)

Harnessing the Natural Biology of Adeno-Associated Virus to Enhance the Efficacy of Cancer Gene Therapy
by: Jacquelyn J. Bower, et al.
Published: (2021-06-01)

Adeno-associated virus vector-based gene therapies for pediatric diseases
by: Kazuhiro Muramatsu, et al.
Published: (2023-02-01)

Characteristics and advantages of adeno-associated virus vector-mediated gene therapy for neurodegenerative diseases
by: Yuan Qu, et al.
Published: (2019-01-01)

Reciprocal mutations of lung-tropic AAV capsids lead to improved transduction properties
by: Ashley L. Cooney, et al.
Published: (2023-11-01)

Microglia targeting by adeno-associated viral vectors
by: Maria Stamataki, et al.
Published: (2024-07-01)

Comparison of Different Liquid Chromatography-Based Purification Strategies for Adeno-Associated Virus Vectors
by: Ruth Rieser, et al.
Published: (2021-05-01)

Recent advances in various adeno-associated viruses (AAVs) as gene therapy agents in hepatocellular carcinoma
by: Meead Hadi, et al.
Published: (2024-01-01)

Targeted gene silencing in mouse testicular Sertoli and Leydig cells using adeno-associated virus vectors
by: Jing Pang, et al.
Published: (2025-09-01)

Advances in Bioanalytical Techniques and Pharmacokinetics/Pharmacodynamics Research of Adeno-Associated Viral Vector Gene Therapy Drugs
by: REN Jianwei, et al.
Published: (2024-07-01)

Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors
by: Zachary J. Tickner, et al.
Published: (2021-06-01)

Production and characterization of an AAV1-VP3-only capsid: An analytical benchmark standard
by: Mario Mietzsch, et al.
Published: (2023-06-01)

Adeno-associated virus 2-mediated gene therapy decreases autofluorescent storage material and increases brain mass in a murine model of infantile neuronal ceroid lipofuscinosis
by: Megan Griffey, et al.
Published: (2004-07-01)

Adeno-Associated Virus Vectors: Principles, Practices, and Prospects in Gene Therapy
by: Limor Zwi-Dantsis, et al.
Published: (2025-02-01)

Comparative in vivo characterization of newly discovered myotropic adeno-associated vectors
by: Jacqueline Ji, et al.
Published: (2024-05-01)

Gene therapy of neurodegenerative diseases: achievements, developments, and clinical implementation challenges
by: E. V. Melnikova, et al.
Published: (2023-06-01)

Revolutionizing Huntington’s Disease Treatment: Breakthroughs in AAV-Mediated Gene Therapy
by: Pedram Moeini Gavgani, et al.
Published: (2025-09-01)

Recombinant adeno-associated virus 8 vector in gene therapy: Opportunities and challenges
by: Liyuan Zhao, et al.
Published: (2024-01-01)

Adeno-Associated Virus Mediated Gene Therapy for Corneal Diseases
by: Prabhakar Bastola, et al.
Published: (2020-08-01)

Seroprevalence of adeno-associated virus types 1, 2, 3, 4, 5, 6, 8, and 9 in a Basque cohort of healthy donors
by: Miguel Navarro-Oliveros, et al.
Published: (2024-07-01)

Co-transduction of dual-adeno-associated virus vectors in the neonatal and adult mouse utricles
by: Zhong-Rui Chen, et al.
Published: (2022-10-01)

Use of a Hybrid Adeno-Associated Viral Vector Transposon System to Deliver the Insulin Gene to Diabetic NOD Mice
by: Que T. La, et al.
Published: (2020-10-01)